AllianceBernstein’s TherapeuticsMD TXMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-5,064
| Closed | -$96K | – | 3380 |
|
|
2022
Q1 | $96K | Sell |
5,064
-1,288
| -20% | -$20.3K | ﹤0.01% | 3118 |
|
|
2021
Q4 | $113K | Sell |
6,352
-73
| -1% | -$2.19K | ﹤0.01% | 3176 |
|
|
2021
Q3 | $238K | Sell |
6,425
-1,270
| -17% | -$56.4K | ﹤0.01% | 3040 |
|
|
2021
Q2 | $458K | Buy |
7,695
+1,924
| +33% | +$117K | ﹤0.01% | 2844 |
|
|
2021
Q1 | $387K | Hold |
5,771
| – | – | ﹤0.01% | 2790 |
|
|
2020
Q4 | $349K | Sell |
5,771
-1,500
| -21% | -$102K | ﹤0.01% | 2780 |
|
|
2020
Q3 | $574K | Sell |
7,271
-3,652
| -33% | -$291K | ﹤0.01% | 2461 |
|
|
2020
Q2 | $683K | Buy |
10,923
+4,450
| +69% | +$259K | ﹤0.01% | 2420 |
|
|
2020
Q1 | $343K | Buy |
6,473
+922
| +17% | +$91.4K | ﹤0.01% | 2548 |
|
|
2019
Q4 | $672K | Hold |
5,551
| – | – | ﹤0.01% | 2429 |
|
|
2019
Q3 | $1.01M | Buy |
5,551
+472
| +9% | +$66.5K | ﹤0.01% | 2245 |
|
|
2019
Q2 | $660K | Buy |
5,079
+32
| +0.6% | +$5.74K | ﹤0.01% | 2491 |
|
|
2019
Q1 | $1.23M | Hold |
5,047
| – | – | ﹤0.01% | 2163 |
|
|
2018
Q4 | $961K | Sell |
5,047
-642
| -11% | -$157K | ﹤0.01% | 2211 |
|
|
2018
Q3 | $1.87M | Hold |
5,689
| – | – | ﹤0.01% | 1991 |
|
|
2018
Q2 | $1.77M | Buy |
5,689
+604
| +12% | +$185K | ﹤0.01% | 2015 |
|
|
2018
Q1 | $1.24M | Hold |
5,085
| – | – | ﹤0.01% | 2128 |
|
|
2017
Q4 | $1.54M | Hold |
5,085
| – | – | ﹤0.01% | 2032 |
|
|
2017
Q3 | $1.34M | Hold |
5,085
| – | – | ﹤0.01% | 2116 |
|
|
2017
Q2 | $1.34M | Buy |
5,085
+494
| +11% | +$124K | ﹤0.01% | 2136 |
|
|
2017
Q1 | $1.65M | Sell |
4,591
-56
| -1% | -$17.3K | ﹤0.01% | 1939 |
|
|
2016
Q4 | $1.34M | Hold |
4,647
| – | – | ﹤0.01% | 2114 |
|
|
2016
Q3 | $1.58M | Hold |
4,647
| – | – | ﹤0.01% | 1946 |
|
|
2016
Q2 | $1.98M | Buy |
4,647
+604
| +15% | +$249K | ﹤0.01% | 1726 |
|
|
2016
Q1 | $1.29M | Hold |
4,043
| – | – | ﹤0.01% | 1934 |
|
|
2015
Q4 | $2.1M | Hold |
4,043
| – | – | ﹤0.01% | 1573 |
|
|
2015
Q3 | $1.19M | Sell |
4,043
-7
| -0.2% | -$2.49K | ﹤0.01% | 2052 |
|
|
2015
Q2 | $1.59M | Buy |
4,050
+1,314
| +48% | +$464K | ﹤0.01% | 1979 |
|
|
2015
Q1 | $828K | Hold |
2,736
| – | – | ﹤0.01% | 2283 |
|
|
2014
Q4 | $609K | Sell |
2,736
-128
| -4% | -$26.4K | ﹤0.01% | 2445 |
|
|
2014
Q3 | $664K | Hold |
2,864
| – | – | ﹤0.01% | 2412 |
|
|
2014
Q2 | $633K | Buy |
2,864
+256
| +10% | +$57K | ﹤0.01% | 2454 |
|
|
2014
Q1 | $823K | Buy |
2,608
+2,574
| +7,571% | +$820K | ﹤0.01% | 2253 |
|
|
2013
Q4 | $9K | Sell |
34
-4
| -11% | -$876 | ﹤0.01% | 3115 |
|
|
2013
Q3 | $6K | Sell |
38
-65
| -63% | -$7.86K | ﹤0.01% | 3195 |
|
|
2013
Q2 | $16K | Buy |
+103
| New | +$14.1K | ﹤0.01% | 3089 |
|
Other funds holding TXMD
RCMNY
E
GF
AllianceBernstein's TXMD Position: Q2 2022 in Review
AllianceBernstein sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 5,064 shares — an estimated $96K sold.
AllianceBernstein first reported a position in TXMD in Q2 2013 and held it in 36 quarters. The position peaked at $2.1M in Q4 2015. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.
- AllianceBernstein reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
- AllianceBernstein sold 5,064 TherapeuticsMD shares in Q2 2022, an estimated $96K.
- AllianceBernstein first reported a position in TherapeuticsMD in Q2 2013 and held it in 36 quarters.
- AllianceBernstein's TherapeuticsMD position peaked at $2.1M in Q4 2015.
- 53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.
Based on AllianceBernstein's 13F filing for Q2 2022, filed 15 Aug 2022.